GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human MDM2 with a dihydroimidazothiazole inhibitor

Analyse Crystal structure of human MDM2 with a dihydroimidazothiazole inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3VZV
Type
protein
Length
170 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
E3 ubiquitin-protein ligase MDM2
EC
6.3.2.-
UniProt
Q00987
Ligands
VZV
Pockets
2 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BE3 ubiquitin-protein ligase MDM2 (EC 6.3.2.-)protein8544% helix, 15% strandQ00987

Ligands and binding sites

  • VZV · 1-{[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-(propan-2-yl)-5,6-dihydroimidazo[2,1-b][1,3]thiazol-2-yl]carbonyl}-N,N-dimethyl-L-prolinamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15000.690.7937VZV
2970.430.7718VZV

Interfaces

1 interface between chains.

  • A–B · 603 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 3VZV · Crystal structure of human mdm2 with a dihydroimidazothiazole inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.